Back to VRTX
Rhenman & Partners Asset Management AB → VRTX
Rhenman & Partners Asset Management AB VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
4
Latest value
$25.6M
Q3 2026
Peak value
$25.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $15.5M |
| Q1 2026 | $19.4M |
| Q2 2026 | $15.2M |
| Q3 2026 | $25.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $25.6M | 48.9K | — | — |
| Q2 2026 | $15.2M | 30.7K | — | — |
| Q1 2026 | $19.4M | 43.5K | — | — |
| Q4 2025 | $15.5M | 34.3K | — | — |